{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:05:56Z","timestamp":1778861156956,"version":"3.51.4"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"46","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,7]]},"DOI":"10.1093\/eurheartj\/ehad136","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T13:32:55Z","timestamp":1683984775000},"page":"4890-4892","source":"Crossref","is-referenced-by-count":4,"title":["Best timing for exercise in breast cancer patients initiating chemotherapy: what is the answer?"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-7830","authenticated-orcid":false,"given":"Ana","family":"Abreu","sequence":"first","affiliation":[{"name":"Cardiology Department, Cardiovascular Rehabilitation Unit, Centro Hospitalar Universit\u00e1rio Lisboa Norte, CAML, Instituto Sa\u00fade Ambiental ISAMB, TERRA, IMPSP, CCUL@RISE, Faculdade de Medicina, Universidade de Lisboa , Av. Professor Egas Moniz , Lisboa, Portugal"}]}],"member":"286","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"2023120714413069400_ehad136-B1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3389\/fonc.2020.00864","article-title":"Breast cancer survivorship, quality of life, and late toxicities","volume":"10","author":"Nardin","year":"2020","journal-title":"Front Oncol"},{"key":"2023120714413069400_ehad136-B2","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1093\/eurheartj\/ehad085","article-title":"Timing of exercise therapy in patients initiating adjuvant chemotherapy for breast cancer: a randomized controlled trial","volume":"44","author":"Scott","year":"2023","journal-title":"Eur Heart J"},{"key":"2023120714413069400_ehad136-B3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/2047487319874900","article-title":"The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology","volume":"28","author":"D'Ascenzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2023120714413069400_ehad136-B4","author":"Wilhelm"},{"key":"2023120714413069400_ehad136-B5","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/cancers14092288","article-title":"The beneficial role of physical exercise on anthracyclines induced cardiotoxicity in breast cancer patients","volume":"14","author":"Tranchita","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2023120714413069400_ehad136-B6","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2023120714413069400_ehad136-B7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jshs.2020.07.008","article-title":"Roles and molecular mechanisms of physical exercise in cancer prevention and treatment","volume":"10","author":"Wang","year":"2021","journal-title":"J Sport Health Sci"},{"key":"2023120714413069400_ehad136-B8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaccao.2022.07.006","article-title":"Optimal timing of a physical exercise intervention to improve cardiorespiratory fitness: during or after chemotherapy","volume":"4","author":"Van der Schoot","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2023120714413069400_ehad136-B9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2018.36.15_suppl.6540","article-title":"Patient comorbid condition and cancer clinical trial participation","volume":"36","author":"Unger","year":"2018","journal-title":"J Clin Oncol"},{"key":"2023120714413069400_ehad136-B10","first-page":"e997","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcome in cancer patients and survivors: a scientific statement from the American Heart Association","volume":"319","author":"Gilchrist","year":"2019","journal-title":"Circulation"},{"key":"2023120714413069400_ehad136-B11","first-page":"543","article-title":"Telerehabilitation for patients with cancer: a scoping review","volume":"290","author":"Rocco","year":"2022","journal-title":"Stud Health Technol Inform"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/46\/4890\/54041804\/ehad136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/46\/4890\/54041804\/ehad136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T21:36:00Z","timestamp":1702416960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/46\/4890\/7161648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":11,"journal-issue":{"issue":"46","published-online":{"date-parts":[[2023,5,13]]},"published-print":{"date-parts":[[2023,12,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad136","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,7]]},"published":{"date-parts":[[2023,5,13]]}}}